Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Trading Update

19 Jan 2010 07:00

RNS Number : 7435F
Cello Group plc
19 January 2010
 



19 January 2010

  

Cello Group plc

Pre-Close trading update - year ended 31 December 2009

Cello Group plc (AIM: CLL, 'the Group'),  the leading independent market research and consulting group, today publishes the following pre-close trading update for the year ended 31 December 2009 Since the announcement of the Group's interim results published in early September, there has been a marked pick up in its market research activity from a wide range of domestic and international clients, in addition to continued strength in the core pharmaceutical operation. However, this has been offset by a challenging period for aspects of the Tangible division of the Group, most notably in financial services and certain charity related work where the traditional seasonal pick up in client activity was not as robust as anticipated. The Tangible operations based in Scotland have had a strong year. Total Group revenue is expected to be in the region of £60.0m.

As highlighted in the interim results, the Group's cost reduction programme continued in the second halfThe total cost base in 2009 is expected to be between £4.0m and £4.5m lower than 2008 as a result of reduced headcount and property consolidation, which will give rise to an exceptional cost of around £1.9m.

As a result, the Board anticipates that the Group's headline profit before tax will be approximately £5.0m.The Group's strong cash conversion continued in the second half of 2009, as a result of which the Board expects to report year end net debt of between £11.5m and £12.0m, down from £14.8m on 30 June 2009.Whilst the Board remains realistically cautious about the current outlook and it is too early to give detailed guidance for 2010, the Group is seeing refreshed levels of spend across major research clients, with pharmaceutical and health related research showing particular strengthThe pipeline of research work is significantly stronger than at the same time last year. Therefore, following the substantial reduction in low margin and non-profitable activities, the Group is in a strong position to push for organic growth in 2010. The Group expects to announce its preliminary results for the year ended 31 December 2009 on Wednesday 17 March 2010. 

 

Enquiries:

 

Cello Group 

 020 7812 8460

Mark ScottChief Executive

Mark Bentley, Finance Director

 

Altium 

 020 7484 4040

Ben Thorne

Paul Chamberlain

 

College Hill

 020 7457 2020

Adrian Duffield/Rozi Morris

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAXFPFELEEFF
Date   Source Headline
14th Sep 20167:00 amRNSInterim Results
9th Sep 20163:45 pmRNSBlock listing Interim Review
31st Aug 20162:29 pmRNSTotal Voting Rights
2nd Aug 201610:50 amRNSTotal Voting Rights
26th Jul 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Jun 201610:19 amRNSTotal Voting Rights
20th Jun 20163:14 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:42 pmRNSAdditional Listing and Total Voting Rights
31st May 20168:58 amRNSTotal Voting Rights
20th May 20162:33 pmRNSReplacement: Director/PDMR Shareholding
20th May 20161:30 pmRNSDirector/PDMR Shareholding
18th May 201612:12 pmRNSGrant of Options
16th May 20167:00 amRNSVAT Update
10th May 20163:30 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement
29th Apr 20167:00 amRNSTotal Voting Rights
15th Apr 20165:03 pmRNSAnnual Report and notice of AGM
1st Apr 20169:02 amRNSTotal Voting Rights
23rd Mar 20164:21 pmRNSVAT Update
17th Mar 20167:00 amRNSPreliminary Results
1st Mar 201612:52 pmRNSBlocklisting Interim Review
29th Feb 201612:05 pmRNSTotal Voting Rights
29th Feb 20169:57 amRNSAdoption of Financial Reporting Standard (FRS) 101
10th Feb 20163:58 pmRNSHolding(s) in Company
29th Jan 20169:33 amRNSTotal Voting Rights
27th Jan 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Oct 20159:25 amRNSTotal Voting Rights
8th Oct 20151:11 pmRNSAdditional Block Listing
30th Sep 20151:15 pmRNSTotal Voting Rights
28th Sep 20152:39 pmRNSHolding(s) in Company
23rd Sep 20152:20 pmRNSHolding(s) in Company
16th Sep 20154:55 pmRNSInterim Dividend Timetable
16th Sep 20157:00 amRNSInterim Results
28th Aug 201510:46 amRNSTotal Voting Rights
12th Aug 201511:57 amRNSBlocklisting Interim Review
31st Jul 201510:13 amRNSTotal Voting Rights
21st Jul 20157:00 amRNSTrading update
1st Jul 20154:20 pmRNSHolding(s) in Company
1st Jul 20151:30 pmRNSTotal Voting Rights
29th May 201511:08 amRNSTotal Voting Rights
15th May 20157:00 amRNSAdditional Listing / TVR
12th May 20151:08 pmRNSResults of Annual General Meeting
12th May 20157:00 amRNSAGM Statement
1st May 201510:43 amRNSTotal Voting Rights
20th Apr 20158:45 amRNSAnnual Report and Accounts 2014 and Notice of AGM
31st Mar 201510:17 amRNSTotal Voting Rights
19th Mar 20157:00 amRNSFinal Results
27th Feb 201511:27 amRNSTotal Voting Rights
9th Feb 20151:34 pmRNSUpdate on potential VAT assessment
2nd Feb 20158:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.